Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1976 1
1987 1
1988 2
1991 3
1992 3
1993 2
1994 1
1996 3
1997 3
1998 3
1999 3
2000 10
2001 12
2002 12
2003 20
2004 29
2005 43
2006 47
2007 59
2008 76
2009 73
2010 87
2011 111
2012 114
2013 137
2014 161
2015 173
2016 151
2017 177
2018 186
2019 201
2020 215
2021 222
2022 252
2023 229
2024 46

Text availability

Article attribute

Article type

Publication date

Search Results

2,540 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations on the use of azole antifungals in hematology-oncology patients.
Azanza JR, Mensa J, Barberán J, Vázquez L, Pérez de Oteyza J, Kwon M, Yáñez L, Aguado JM, Cubillo Gracian A, Solano C, Ruiz Camps I, Fortún J, Salavert Lletí M, Gudiol C, Olave Rubio T, Solano C, García-Vidal C, Rovira Tarrats M, Suárez-Lledó Grande M, González-Sierra P, Dueñas Gutiérrez C. Azanza JR, et al. Among authors: kwon m. Rev Esp Quimioter. 2023 Jun;36(3):236-258. doi: 10.37201/req/013.2023. Epub 2023 Apr 5. Rev Esp Quimioter. 2023. PMID: 37017117 Free PMC article. Review.
Post-stroke Everything.
Lekoubou A, Nguyen C, Kwon M, Nyalundja AD, Agrawal A. Lekoubou A, et al. Among authors: kwon m. Curr Neurol Neurosci Rep. 2023 Nov;23(11):785-800. doi: 10.1007/s11910-023-01308-9. Epub 2023 Oct 14. Curr Neurol Neurosci Rep. 2023. PMID: 37837566 Review.
The Mortality Burden of Untreated Aortic Stenosis.
Généreux P, Sharma RP, Cubeddu RJ, Aaron L, Abdelfattah OM, Koulogiannis KP, Marcoff L, Naguib M, Kapadia SR, Makkar RR, Thourani VH, van Boxtel BS, Cohen DJ, Dobbles M, Barnhart GR, Kwon M, Pibarot P, Leon MB, Gillam LD. Généreux P, et al. Among authors: kwon m. J Am Coll Cardiol. 2023 Nov 28;82(22):2101-2109. doi: 10.1016/j.jacc.2023.09.796. Epub 2023 Oct 24. J Am Coll Cardiol. 2023. PMID: 37877909 Free article.
Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease.
Yang H, Park SY, Baek H, Lee C, Chung G, Liu X, Lee JH, Kim B, Kwon M, Choi H, Kim HJ, Kim JY, Kim Y, Lee YS, Lee G, Kim SK, Kim JS, Chang YT, Jung WS, Kim KH, Bae H. Yang H, et al. Among authors: kwon m. Theranostics. 2022 Nov 7;12(18):7668-7680. doi: 10.7150/thno.75965. eCollection 2022. Theranostics. 2022. PMID: 36451854 Free PMC article.
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy.
Gazeau N, Liang EC, Wu QV, Voutsinas JM, Barba P, Iacoboni G, Kwon M, Ortega JLR, López-Corral L, Hernani R, Ortiz-Maldonado V, Martínez-Cibrian N, Martinez AP, Maziarz RT, Williamson S, Nemecek ER, Shadman M, Cowan AJ, Green DJ, Kimble E, Hirayama AV, Maloney DG, Turtle CJ, Gauthier J. Gazeau N, et al. Among authors: kwon m. Transplant Cell Ther. 2023 Jul;29(7):430-437. doi: 10.1016/j.jtct.2023.04.001. Epub 2023 Apr 7. Transplant Cell Ther. 2023. PMID: 37031746
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma.
Kwon M, Iacoboni G, Reguera JL, Corral LL, Morales RH, Ortiz-Maldonado V, Guerreiro M, Caballero AC, Domínguez MLG, Pina JMS, Mussetti A, Sancho JM, Bastos-Oreiro M, Catala E, Delgado J, Henriquez HL, Sanz J, Calbacho M, Bailén R, Carpio C, Ribera JM, Sureda A, Briones J, Hernandez-Boluda JC, Cebrián NM, Martin JLD, Martín A, Barba P. Kwon M, et al. Haematologica. 2023 Jan 1;108(1):110-121. doi: 10.3324/haematol.2022.280805. Haematologica. 2023. PMID: 35770532 Free PMC article.
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy.
Kim R, Kwon M, An M, Kim ST, Smith SA, Loembé AB, Mortimer PGS, Armenia J, Lukashchuk N, Shah N, Dean E, Park WY, Lee J. Kim R, et al. Among authors: kwon m. Ann Oncol. 2022 Feb;33(2):193-203. doi: 10.1016/j.annonc.2021.10.009. Epub 2021 Oct 25. Ann Oncol. 2022. PMID: 34710570 Free article. Clinical Trial.
2,540 results